This report analyzes the current and potential world market for medical MRI and ultrasound systems. This report generally reviews the nature and direction of research, as well as future markets for two key areas of imaging technology: Ultrasound and MRI.
The report includes the following as part of its market coverage:
The information presented in Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives, clinicians and researchers.
The market for MRI continues to grow despite the recession and weak recovery. Ultrasound continues to be a low-cost and effective imaging technology that can help radiologists and others gather significant clinical data about patients. MRI has been propelled by improved image quality facilitated by higher field strength magnets and the development of new techniques for evaluating specific portions of the complex structures in the brain. This demand has led to new applications and markets for the modality. Ultrasound is well suited to many patients. No other imaging option gives patients a real-time look at their anatomy or openly encourages discussions with physicians about their symptoms and the evidence of disease on the monitor. Ultrasound is safe, patient-friendly and inexpensive. The adoption of this modality by hospitals and other healthcare institutions has generated new market opportunities for manufacturers of ultrasound systems and components suppliers.
As part of its extensive coverage into the market for these two important diagnostic modalities, the report profiles many companies who produce and market MRI and/or ultrasound systems. Siemens, GE Healthcare, Philips, Fonar, Toshiba, Hitachi Aloka, Esaote are the among the companies profiled, providing the latest information on these leaders, but Kalorama also looks at the smaller companies who make systems and handheld units that are competitive. The technology these companies have introduced is discussed, along with significant market results. This provides market watchers with an accurate look at the type of companies that could earn a larger share of the market in the future.
Imaging companies are increasingly seeking emerging markets for their products as world healthcare systems demand better diagnostic systems. In this edition, Kalorama takes a deeper look into world markets for MRI and ultrasound, including European country-level markets and BRIC markets. For both MRI and Ultrasound, the report includes the following:
Among the many developments in this market, ultrasound is benefiting from scrutiny of CT scans. A 2011 study by Tel Aviv University exploring the efficacy of expensive and invasive CT scans has found that, in some cases, they do not offer a clinical advantage over a simple, inexpensive ultrasound procedure. In his study, Dr. Michael Vaiman of Tel Aviv University's Sackler Faculty of Medicine compared the efficacy of CT against ultrasound scans for locating vertebral arteries in the throat, an important assessment that must be completed before a surgeon operates in the neck area of the body. After comparing the outcomes of 250 CT scans with 500 ultrasound images, he concluded that there is no advantage to using CT scans for most of these procedures, especially those that are used to locate anomalies in the neck to map major arteries before surgery can take place.
Browse more CT MRI Xray Market Research Reports